Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China

Condition:   Multidrug Resistant Tuberculosis Intervention:   Drug: Delamanid Sponsor:   Beijing Chest Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials